USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Enzychem Lifesciences Corporation

USPTO PatentsView assignee record - 22 granted patents across 11 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Enzychem ranks #13,410 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 11 technology areas.

#13,410
of 49,997 US assignees by volume
47th percentile
by Innovation Score (34.3/100)
13.3
avg claims per patent
+133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13410 · Foreign Corporation #13,410 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 22 grants
  • MID-PACK #13,410/49,997
  • PHOTO-FINISH Eberhard Karls…
  • CPC-FOCUS A61K · 11 areas
  • INNOV-THIN 34.3/100
  • CLAIMS-RICH 13.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +133% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Enzychem’s 34.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Enzychem

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Enzychem's Innovation Score is 34.3/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Enzychem?

Each dot is one of Enzychem’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Enzychem’s own 13.3 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Enzychem vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 21.921.92222.1 510152025 Granted patents (volume) Avg claims / patent Elkamet Kunststofftechnik GMBH - 22, 20.55Elkamet Kunststof…Emerson Paradigm Holding LLC - 22, 22.36Emerson Paradigm…Emtensor GMBH - 22, 22.14EmtensorEnterpriseweb LLC - 22, 22EnterprisewebErni Production GmbH & Co. KG - 22, 9.55Erni Production &…ESBATech, an Alcon Biomedical Research Unit LLC - 22, 10.36Esbatech an Alcon…Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet - 22, 12.05Eberhard Karls Un…Edmonds Outdoors, LLC - 22, 7.64Edmonds OutdoorsEnzychem Lifesciences Corporation - 22, 13.32Enzychem Lifescie…
Enzychem vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Enzychem's grants concentrate

Enzychem Lifesciences Corporation is a focused PatentsView assignee: 11 CPC subclasses with 90.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (6 grants) versus a trough of 1 in 2023. By volume, Enzychem sits between Elkamet Kunststofftechnik GMBH and Edmonds Outdoors, LLC.

Enzychem's three-year grant acceleration

Enzychem Lifesciences Corporation shows 5 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Enzychem's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Enzychem holds 22 patents at rank #13,399, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Enzychem

By rank, the assignees closest to #13,399 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Enzychem's primary technology class.

Enzychem's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 20172018202020212022202320242025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Enzychem Lifesciences Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 3 13.6%
2018 3 13.6%
2020 6 27.3%
2021 3 13.6%
2022 3 13.6%
2023 1 4.5%
2024 1 4.5%
2025partial year 2 9.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Enzychem Lifesciences Corporation's patent record in context - here's where to go next.

  • Enzychem Lifesciences Corporation's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90.9% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #13,410 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Enzychem Lifesciences Corporation against Elkamet Kunststofftechnik GMBH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.